Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulf Siemoneit

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
European Journal of Pharmacology|February 26, 2009
MK-886, an inhibitor of the 5-lipoxygenase-activating protein, inhibits cyclooxygenase-1 activity and suppresses platelet aggregationAndreas Koeberle, Ulf Siemoneit, Hinnak Northoff, et al.
European Journal of Pharmacology|April 21, 2009
On the interference of boswellic acids with 5-lipoxygenase: mechanistic studies in vitro and pharmacological relevanceUlf Siemoneit, Carlo Pergola, Bianca Jazzar, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 14, 2008
Licofelone suppresses prostaglandin E2 formation by interference with the inducible microsomal prostaglandin E2 synthase-1Andreas Koeberle, Ulf Siemoneit, Ulrike Bühring, et al.
Planta Medica|April 14, 2017
Defined Structure-Activity Relationships of Boswellic Acids Determine Modulation of Ca2+ Mobilization and Aggregation of Human Platelets by Boswellia serrata ExtractsUlf Siemoneit, Lars Tausch, Daniel Poeckel, et al.
International Journal of Pharmaceutics|February 9, 2006
Acrylic/cyclodextrin hydrogels with enhanced drug loading and sustained release capabilityUlf Siemoneit, Christoph Schmitt, Carmen Alvarez-Lorenzo, et al.
Biochemical Pharmacology|October 20, 2007
Identification and functional analysis of cyclooxygenase-1 as a molecular target of boswellic acidsUlf Siemoneit, Bettina Hofmann, Nicole Kather, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 4, 2009
Identification of human cathepsin G as a functional target of boswellic acids from the anti-inflammatory remedy frankincenseLars Tausch, Arne Henkel, Ulf Siemoneit, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
European Journal of Pharmacology|February 26, 2009
MK-886, an inhibitor of the 5-lipoxygenase-activating protein, inhibits cyclooxygenase-1 activity and suppresses platelet aggregationAndreas Koeberle, Ulf Siemoneit, Hinnak Northoff, et al.
European Journal of Pharmacology|April 21, 2009
On the interference of boswellic acids with 5-lipoxygenase: mechanistic studies in vitro and pharmacological relevanceUlf Siemoneit, Carlo Pergola, Bianca Jazzar, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 14, 2008
Licofelone suppresses prostaglandin E2 formation by interference with the inducible microsomal prostaglandin E2 synthase-1Andreas Koeberle, Ulf Siemoneit, Ulrike Bühring, et al.
Planta Medica|April 14, 2017
Defined Structure-Activity Relationships of Boswellic Acids Determine Modulation of Ca2+ Mobilization and Aggregation of Human Platelets by Boswellia serrata ExtractsUlf Siemoneit, Lars Tausch, Daniel Poeckel, et al.
International Journal of Pharmaceutics|February 9, 2006
Acrylic/cyclodextrin hydrogels with enhanced drug loading and sustained release capabilityUlf Siemoneit, Christoph Schmitt, Carmen Alvarez-Lorenzo, et al.
Biochemical Pharmacology|October 20, 2007
Identification and functional analysis of cyclooxygenase-1 as a molecular target of boswellic acidsUlf Siemoneit, Bettina Hofmann, Nicole Kather, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 4, 2009
Identification of human cathepsin G as a functional target of boswellic acids from the anti-inflammatory remedy frankincenseLars Tausch, Arne Henkel, Ulf Siemoneit, et al.
Pageof 1